Long COVID: Higher Rates in Women
A new study reveals women face substantially higher risks of developing long COVID than men. The research, published in JAMA Network Open, analyzed data from over 12,200 participants, finding women had a 31% to 44% higher risk. Factors like age, pregnancy, and menopause influence these outcomes. The findings highlight the need for more understanding of sex-specific differences in chronic illnesses. Scientists explore the roles of immune systems and hormones like estrogen and testosterone. News Directory 3 provides this critical update, emphasizing the importance of taking symptoms seriously and seeking medical advice. Future research aims to develop targeted therapies for those affected. Understanding the role of gender in long COVID is vital. Discover what’s next as scientists delve deeper into its long-term impacts.
Long COVID: Study Shows Women Face Higher Risks
Women are considerably more likely to develop long COVID than men, according to a new study from the National Institutes of Health RECOVER initiative. The research, published in JAMA Network Open, analyzed data from over 12,200 participants infected with COVID-19 between 2021 and 2024.
The study found that women had a 31% to 44% higher risk of developing long COVID, even after adjusting for clinical and demographic factors.This disparity was most pronounced among nonpregnant, nonmenopausal women.
Dr. Dimpy Shah, assistant professor of population health sciences at The University of Texas health Science Center at San Antonio and lead author of the study, noted that age, pregnancy, and menopause all influence long COVID risk. “that is a very novel finding,” Shah said.
For Letícia Soares, a Brazilian scientist, long COVID brought a host of debilitating symptoms, including menstrual changes.”It just baffled me,” said Soares, now 40, who experienced a complete disappearance of her period followed by prolonged, heavy bleeding.
Scientists are increasingly focused on understanding the biologic sex disparity in chronic illnesses like long COVID. Akiko Iwasaki, an immunologist at Yale University, said that women’s immune systems may be more prone to autoimmune reactions due to having two X chromosomes.
Hormones also play a role. Testosterone,which is higher in men,is immunosuppressive,while estrogen,which is higher in women,enhances the immune response. This heightened response may contribute to persistent inflammation in long COVID.
Beth Pollack, a research scientist at MIT, emphasized the need to address knowledge gaps around sex differences to improve understanding of complex chronic illnesses.She co-authored a 2023 literature review of female reproductive health impacts of long COVID.
Researchers are also examining why long COVID rates are disproportionately high in the trans community. J.D. Davids, a trans patient-researcher, said socioeconomic factors must be considered.
Iwasaki hopes that a simple blood test to diagnose long COVID will change perceptions of the condition and ensure it is indeed treated with the seriousness it deserves.
Shah advises women to take their symptoms seriously and consult with their physicians. “It’s a call to action,” Shah said.
What’s next
Future research will focus on the biologic mechanisms contributing to sex specificity in long COVID, with the goal of developing targeted therapies and improving diagnosis and treatment.